blood testing

R&D

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

News

An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.

Oncology

Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.

News

Reported settlement of around $25 million significantly reduces company funds.

News

Agreement could cost Theranos $30 million - significantly less than original $140 million lawsuit.

News

Firm also agrees not to own or operate a lab within two years.